BLOG

Monday, June 24, 2019

Can deprescribing drugs linked to cognitive impairment actually reduce risk of dementia?

Scientists call for randomized deprescribing trials to address anticholinergic drug use as a potentially modifiable and reversible risk factor for dementia, a growing public health issue.

from Top Health News -- ScienceDaily http://bit.ly/2LeFV8r

No comments:

Post a Comment

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...